Why baby's sex may influence risk of pregnancy-related complicatations

Pregnancy
Pregnancy test. Credit: public domain

The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother's blood, which may explain why risks of some diseases in pregnancy vary depending whether the mother is carrying a boy or a girl, according to new research from the University of Cambridge.

The findings, published today in JCI Insight, help to explain, for example, why male in the womb may be more vulnerable to the effects of poor growth, and why being pregnant with a girl may lead to an increased risk of severe pre-eclampsia for the mother.

A team led by researchers at the Department of Obstetrics and Gynaecology, NIHR Cambridge Biomedical Research Centre, performed detailed scientific studies of more than 4,000 first time mothers and analysed samples of and maternal blood.

They found that the genetic profile of the placentas of male and female babies were very different in relation to the baby's sex. Many of the genes that differed according to the sex of the baby in the placenta had not previously been seen to differ by sex in other tissues of the body.

The team found that one of these uniquely sex-related placental genes controlled the level of a small molecule called spermine. Spermine is a metabolite—a substance involved in metabolism—that plays an important role in all cells and is even essential for the growth of some bacteria.

Female placentas had much of the enzyme that makes spermine, and mothers pregnant with baby had higher levels of a form of spermine in their blood compared to mothers pregnant with baby boys.

Placental cells from boys were also found to be more susceptible to the toxic effects of a drug that blocked spermine production. This provided direct experimental evidence for sex-related differences in the placental metabolism of spermine.

The researchers also found that the form of spermine which was higher in pregnant with a girl was also predictive of the risk of : high levels were associated with an increased risk of pre-eclampsia (where the mother develops and kidney disease), whereas low levels were associated with an increased risk of poor fetal growth.

The patterns observed were all consistent with previous work which has shown that boys may be more vulnerable to the effects of and that being pregnant with a girl may lead to an increased risk of severe preeclampsia.

"In pregnancy and childbirth, the sex of the baby is at the forefront of many parents' minds, but we do not even think of the placenta as having a sex. This work shows that the placenta differs profoundly according to sex," says Professor Gordon Smith from the University of Cambridge, who led the study.

"These differences alter elements of the composition of the mother's blood and may even modify her risk of pregnancy complications. Better understanding of these differences could lead to new predictive tests and possibly even new approaches to reducing the risk of poor outcome."


Explore further

High blood pressure in pregnancy linked to mother's heart function

More information: Sungsam Gong et al, Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia, JCI Insight (2018). DOI: 10.1172/jci.insight.120723
Provided by University of Cambridge
Citation: Why baby's sex may influence risk of pregnancy-related complicatations (2018, July 12) retrieved 18 March 2019 from https://medicalxpress.com/news/2018-07-baby-sex-pregnancy-related-complicatations.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
39 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more